Grants to Support Investigator-Initiated Early-Phase Clinical Trials in Ohio (USA)
GrantID: 64183
Grant Funding Amount Low: $250,000
Deadline: October 2, 2026
Grant Amount High: $1,515,000
Summary
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The program seeks to catalyze breakthroughs in HLBS research, ultimately improving patient outcomes and advancing medical knowledge...
Organizations and individuals based in Ohio who are engaged in Municipalities may be eligible to apply for this funding opportunity. To discover more grants that align with your mission and objectives, visit The Grant Portal and explore listings using the Search Grant tool.
Eligible Regions
Interests
Eligible Requirements
